2011 Jan 13
Researchers recruited 338 adults who had a BMI over 30 or a BMI of 2730 with one or more weight-related conditions and were assigned to one of the following experimental groups or a placebo group: 1 mg of subcutaneous retatrutide 4 mg of subcutaneous retatrutide, starting at an initial dose of 2 mg 4 mg of subcutaneous retatrutide, starting at an initial dose of 4 mg 8 mg of subcutaneous retatrutide, starting at an initial dose of 2 mg 8 mg of subcutaneous retatrutide, starting at an initial dose of 4 mg 12 mg of subcutaneous retatrutide, starting at an initial dose of 2 mg The trials promising results pave the way for further phase 3 research to evaluate retatrutides efficacy in comprehensive obesity management and its impact on associated health issues
Overweight, including obesity (BMI 25 kg/m 2
Contact dermatitis is most common in those with sensitive skin, or in individuals using a product with a higher concentration than 1 percent of kojic acid
Rapid weight loss and a decreased appetite can sometimes lead to nutritional deficiencies, such as low vitamin B12 or iron, and cause worsening numbness, weakness, hair loss, or vision trouble
